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Background: Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) occurs in 10%e30% of
patients with RA, and interstitial lung disease (ILD) is associated with increased mortality in up to 10% of
patients with RA. The pathogenesis of RA-ILD is virtually unknown. The aim of this study is to investigate
the proteins related to UIP pattern by comparing to OP pattern in RA-ILD using proteome analysis of
bronchoalveolar lavage ﬂuid (BALF).
Methods: Proteomic differences in BALF were compared between the UIP pattern and OP pattern by
examining BALF from 5 patients with the UIP pattern and 7 patients with the OP pattern by two-
dimensional gel electrophoresis and mass spectrometry.
Results: In individual comparisons of BALF samples, the levels of the protein gelsolin and Ig kappa chain
C region were signiﬁcantly higher in the UIP pattern than in the OP pattern. In contrast, the levels of a-1
antitrypsin, CRP, haptoglobin b, and surfactant protein A (isoform number 5) were all signiﬁcantly higher
in the OP pattern than in the UIP pattern. Gelsolin was cleaved into two fragments, a C-terminal half and
N-terminal half, and the levels of both were signiﬁcantly higher in the UIP pattern than in the OP pattern.
Conclusions: Fragmented gelsolins may be associated with the pathogenesis of ﬁbrosis in RA-ILD.
Copyright © 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Medicine, Tokyo Medical and
113-8519, Japan.
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monoxide; %FEV1.0, percentage of forced
expiratory volume in one second; %
VC, percentage predicted vital capacityIntroduction
Rheumatoid arthritis (RA) is a systemic autoimmune disease of
unknown etiology that affects 0.5e1.0% of the adult population
worldwide.1 Rheumatoid arthritis-associated interstitial lung dis-
ease (RA-ILD) occurs in 10%e30% of patients with RA, and inter-
stitial lung disease (ILD) is associated with increased mortality in
up to 10% of patients with RA. The most common pathological
ﬁndings in RA-ILD are usual interstitial pneumonia (UIP) and non-
speciﬁc interstitial pneumonia (NSIP). Organizing pneumonia (OP)
and lymphocytic interstitial pneumonia are less common, but not
rare.2 RA-ILD patients with UIP have a worse prognosis than those
with OP.3,4 While genetic, clinical, serological, and environmental
factors are thought to contribute to the development of RA-ILD,
little is known about the pathogenesis of the disease.
The actin cytoskeleton plays a central role in many fundamental
cellular processes involving the generation of force and facilitation
of movement, processes enabled by the assembly of actin mono-
mers into ﬁlaments and cooperation with a wide variety of actin
binding proteins (ABPs).5 One particularly abundant ABP is gelsolin,
an actin ﬁlament capping/severing protein cleaved by caspases or
matrix metalloproteinases (MMPs).6,7 Caspase-3, an important
effector of apoptosis, cleaves gelsolin into two fragments.8 The C-
terminal gelsolin fragment (C-gelsolin) is generally anti-apoptotic,
while the N-terminal fragment (N-gelsolin) is pro-apoptotic.5
Increased gelsolin expression correlates with reduced pulmo-
nary function. Gelsolin upregulation has recently been found in
idiopathic pulmonary ﬁbrosis (IPF) and ﬁbrotic NSIP, but not in
other forms of interstitial lung disease. Gelsolin affected both
neutrophil inﬁltration and epithelial apoptosis in a bleomycin- or
lipopolysaccharide-challenged model of lung inﬂammation.5,9
Gelsolin knockout (GSN/) mice were protected from lung
inﬂammation and ﬁbrosis, as well as ventilator-induced lung
injury.9,10 Gelsolin is likely to play a role in RA. Gelsolin expression
leads to severe alterations in cytoskeletal organization and induc-
tion of RA in GSN/ mice, thereby resulting in the exacerbation of
signs of disease.5,11 The combination of reduced plasma gelsolin
and presence of actin and gelsolineactin complexes in synovial
ﬂuids suggest a local consumption of this potentially anti-
inﬂammatory protein in the inﬂamed joint.5,12 While the relation-
ships of gelsolin with pulmonary ﬁbrosis and RA have been re-
ported, there have been no reports on the relationship between
gelsolin and RA-ILD.
The aim of this study is to investigate the proteins related to the
UIP pattern in RA-ILD by comparing themwith the proteins related
to the OP pattern by performing a proteomic analysis of bron-
choalveolar lavage ﬂuid (BALF). We also focused on fragmented
gelsolins, which were observed at higher levels in the UIP pattern,
and studied the relationship between gelsolin and RA-ILD.
Methods
Patients
The study conformed to the Declaration of Helsinki and was
approved by the internal review boards of our institution (No.
1270). The requirement for informed consent was waived. BALF
samples were obtained from 12 patients with RA-ILD in ourhospital between 2001 and 2011. The diagnosis of RAwas based on
the 1987 American College of Rheumatology classiﬁcation criteria.
The patients were divided into two groups, UIP pattern and OP
pattern, based on the ﬁndings of high-resolution computed to-
mography (HRCT). Five patients with the UIP pattern and 7 patients
with the OP pattern were examined. We diagnosed the UIP pattern
by referring from IPF guideline.13 All patients were deﬁnite UIP
pattern and none of them were inconsistent with UIP pattern in
HRCT. One patient underwent surgical lung biopsy. On the other
hand, we diagnosed the OP pattern by clinical, HRCT, BALF, and
transbronchial lung biopsy (TBLB) ﬁndings. Five patients under-
went TBLB.
Clinical data, pulmonary function data on the predicted vital
capacity percentage (%VC) and percentage of forced expiratory
volume in one second (%FEV1.0), and laboratory data on serum
levels of C-reactive protein (CRP), lactate dehydrogenase (LDH),
Krebs von den Lungen-6 (KL-6), and surfactant protein D (SP-D)
were collected. The patients gave their informed consent to un-
dergo bronchoscopy, and none of them were receiving predniso-
lone or other immunosuppressive agents at the time of enrollment.
Bronchoalveolar lavage (BAL)
BAL was performing using three 50-ml aliquots of sterile 0.9%
saline, as previously described.14 The cellular composition of the
BALF was determined by counting 200 cells in a cytospun smear
with Wright's stain. The lymphocyte phenotypes were analyzed by
ﬂow cytometry using monoclonal antibodies for CD4 and CD8.
Two-dimensional gel electrophoresis
Two-dimensional gel electrophoresis (2-DE) was performed as
previously described.15 BALF was concentrated by acetone precip-
itation and diluted in lysis buffer (8 M urea, 4% CHAPS, 65 mM
dithioerythritol, 0.1 M acetic acid, pharmalyte [pH 3 to 10 for iso-
electrofocusing; GE healthcare], and a trace of bromophenol blue)
to a concentration at which 54 ml of samples contained 108 mg of
proteins. Samples of the same volume (54 ml) were loaded on
immobilized pH gradient (IPG) strips (pH 4e7,18 cm; GEhealthcare,
Uppsala, Sweden) in each analytical experiment. The samples were
rehydrated in the strip holder of the IPG-IEF Cool-PhoreStar system
(Anatech, Tokyo, Japan) at 20 C, and isoelectrofocusing was
terminated at 47 kV. The IPG strips were equilibrated ﬁrst in the
urea/SDS/Tris buffer for 30 min and then in the same buffer con-
taining 2.5% iodoacetamide. The second dimensional run was per-
formed on 10% polyacrylamide linear gradient gels at a constant
current of 20e30 mA/gel at 20 C until the dye front reached the
bottom of the gels. The gels were stained with SYPRO-Ruby Protein
Gel Stain (Molecular Probes, Carlsbad, CA, USA).
Evaluation and identiﬁcation of proteins
The gels were scanned using FluoroPhoreStar 3000 (Anatech,
Tokyo, Japan) and analyzed using Progenesis PG220 Software
(Nonlinear Dynamics, Newcastle upon Tyne, UK). The proteins were
analyzed automatically using the spot detection feature of the
software, with automatic warping and matching. Spot volumes
were corrected for background using the “mode of non-spot”
Table 1
Patient characteristics.
Characteristics UIP OP p Value
(n ¼ 5) (n ¼ 7)
Gender
Male 4 3
Female 1 4 0.293
Age (yr) 62 (54e68) 69 (54e73) 0.569
Pack e year 33 (28e43) 5 (0e40) 0.224
Serum CRP (mg/dl) 0.8 (0.3e1.2) 12.0 (8.0e14.0) 0.007**
Serum LDH (IU/l) 236 (201e298) 182 (179e194) 0.042*
Serum KL-6 (U/ml) 1500 (904e1945) 212 (130e359) 0.004**
Serum SP-D (ng/ml) 132 (80e216) 40 (25e72) 0.056
%VC (%) 83.4 (80.9e99.1) 88.2 (71.7e92.9) 0.905
%FEV1.0 (%) 76.4 (73.5e92.5) 83.6 (59.9e86.8) 0.905
BALF proﬁles
Recovery rate (%) 47.3 (32.0e61.7) 46.0 (44.0e54.7) 1.000
Cell density (105/ml) 2.4 (1.9e4.7) 4.5 (3.5e5.3) 0.268
Macrophages (%) 61.0 (56.9e82.6) 83.2 (67.6e93.4) 0.268
Lymphocytes (%) 28.8 (12.3e40.9) 6.5 (5.2e11.3) 0.106
Neutrophils (%) 2.6 (1.3e6.1) 4.6 (2.1e15.3) 0.569
Eosinophils (%) 0.9 (0.3e3.6) 0.6 (0.0e2.5) 0.566
CD4/CD8 3.9 (1.0e6.7) 1.5 (1.0e3.0) 0.527
*p < 0.05, **p < 0.01.
Values are given as the numbers or medians (25th and 75th percentiles).
UIP, usual interstitial pneumonia; OP, organizing pneumonia; KL-6, Krebs von den
Lungen-6; SP-D, surfactant protein D; %VC, percentage of predicted vital capacity; %
FEV1.0, percentage of forced expiratory volume in one second.
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area and density achieved using spot volumes multiplied by the
total area, where the total spot volume was deﬁned as 100. The
normalized spot volumes were compared among the different
clinical groups. The differences between two groups were
conﬁrmed by analyzing the spot quantities of pooled samples of the
UIP pattern or OP pattern. Non-matching spots or spots more than
2-fold higher or lower in quantity were regarded as differentially
expressed in the UIP pattern compared with the OP pattern. Next,
BALF samples of individuals were compared between the two
groups to verify the results.
Proteins were identiﬁed by comparing BALF maps such as the
SWISS-2D PAGE humanplasmamap or published BALFmaps,16,17 or
by liquid chromatography nano electron spray ionization tandem
mass spectrometry (LC-nESI-MS/MS) (QTRAP 5500 LC/MS/MS
System, AB SCIEX, Concord, ON, Canada). The protein spots of in-
terest picked up from the gels were analyzed by LC-nESIMS/MS in
the Laboratory of Cytometry and Proteome Research at Tokyo
Medical and Dental University. LC separation was performed on a
HiQ sil C18W-3P column (0.1 mmF  100 mm, KYA TECH Corpo-
ration, Tokyo, Japan). The proteins were eluted at a ﬂow rate of
300 nL/min using water containing 0.1% (v/v) formic acid as the
eluent A and acetonitrile containing 0.1% (v/v) formic acid as the
eluent B with a linear gradient from 5% B to 45% B in 70 min. The
data were analyzed using ProteinPilotTM software (Version 3,
Applied Biosystems, Warrington, UK).
Western blot
After separation of the SDS-PAGE gels or 2-DE-PAGE gels, the
proteins were electro-transferred onto polyvinylidene diﬂuoride
(PVDF) membranes, blocked with 5% non-fatty dry milk in tris
buffered saline with Tween 20 (TBS-T), washed in TBS-T, and
incubated with anti C-terminal gelsolin antibody (C-20; Santa Cruz
Biotechnology, Santa Cruz, CA, USA) or anti N-terminal gelsolin
antibody (ab75832; Abcam, Cambridge, MA, USA) overnight at 4 C.
After four washings, the membranes were reacted with Cy3-
conjugated donkey anti-goat immunoglobulin (HþL) (Jackson
ImmunoResearch Laboratories, West Grove, PA, USA) for 1 h at
room temperature and then washed again. Proteins were immu-
nodetected using ChemiDoc MP (Bio-Rad Laboratories, Tokyo,
Japan).
Enzyme-linked immunosorbent assay (ELISA)
Since gelsolin is evaluable by ELISA, we measured serum and
BALF gelsolin in a larger group to conﬁrm the results on gelsolin in
the BALF proteome. An ELISA kit (Aviscera Bioscience, Santa Clara,
CA, USA) was used to measure the gelsolin concentration in serum
at a 1:5000 dilution in 14 subjects (8 in the UIP group and 6 in the
OP group) and in BALF at a 1:3 dilution in 14 patients (6 in the UIP
group and 8 in the OP group). The sensitivity of this assay in
detecting gelsolin ranged from 313 to 40,000 pg/ml.
Immunohistochemical analysis
Immunohistochemistry was performed on 4-mm-thick parafﬁn
sections for C-terminal gelsolin (ab74420; Abcam, Cambridge, MA,
USA) and N-terminal gelsolin (ab75832; Abcam). Parafﬁn sections
were autoclaved in an antigen unmasking solution (Vector Labo-
ratories, Burlingame, CA, USA). Endogenous peroxidase was
blocked with 3% H2O2. Endogenous avidin or biotin activity was
blocked with an Avidin/Biotin Blocking kit (Vector Laboratories).
Sections were incubated ﬁrst with anti-gelsolin polyclonal IgG or
anti-gelsolin monoclonal IgG, then with biotinylated secondaryantibodies (goat anti-rabbit IgG, Vector Laboratories). After incu-
bation with an ABC kit (Vector Laboratories), DAB (Nichirei, Tokyo,
Japan) was added. Tissue sections were counterstained with May-
er's hematoxylin and mounted with a cover slip. Nonimmune
rabbit IgG was applied to lung sections as a negative control.
Statistical analysis
All statistical analyses were performed with GraphPad Prism
version 5.2 (GraphPad Software, USA). Data were presented as
means with the 25th and 75th percentiles. The two groups were
compared using the ManneWhitney U test. The two gender groups
were compared using Fisher's test. Correlation coefﬁcients were
obtained using Spearman's correlation coefﬁcient test. All statisti-
cal comparisons were two-sided, and p values of less than 0.05
were considered statistically signiﬁcant.
Results
Patient characteristics
Proteome analysis of individual BALF samples was performed on
12 patients with RA-ILD, that is, 5 with the UIP pattern and 7 with
the OP pattern. The patient characteristics and BALF ﬁndings are
shown in Table 1. The serum CRP level was signiﬁcantly higher in
the OP pattern than in the UIP pattern. Serum KL-6 and LDH levels
were signiﬁcantly higher in the UIP pattern than in the OP pattern.
No difference in BALF proﬁles was observed between the two
groups. No microbiological or clinical evidence of bacterial or
fungal infection was found in any patient.
Two-dimensional gel electrophoresis
We analyzed the BALF proteome in the patients with UIP and
OP patterns by the 2-DE technique to evaluate the differences in
protein expression between the two groups. The 2-DE patterns of
BALF are shown in Fig. 1A. There was no signiﬁcant difference in
Fig 1. Two-dimensional electrophoresis (2-DE) of BALF from an RA-ILD patient with UIP pattern (A) performed using a nonlinearimmunobiline gradient 4e7, IPG strip followed by
10% SDS-PAGE. Proteins were detected by SYPRO-Ruby. Numbers indicate proteins, as listed in Table 2. Representative 2-DE patterns of BALF from the UIP pattern (B) and OP pattern
(C). The square area is magniﬁed in the lower right portion of the ﬁgure. The circled spots are gelsolin identiﬁed by mass spectrometry.
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(386 [352e426] spots vs. 395 [371e475] spots, p ¼ 0.432; Fig. 1B,
C). We identiﬁed 38 species of proteins using LC-nESI-MS/MS and/
or gel matching (GM) with the 2-DE database from Swiss-PROT
(Table 2). In individual comparisons of BALF samples, the levels
of Immunoglobulin kappa chain C region and gelsolin were
signiﬁcantly higher in the UIP pattern than in the OP pattern. In
contrast, the levels of a-1 antitrypsin, CRP, haptoglobin b, and
surfactant protein A (isoform number 5) were signiﬁcantly higher
in the OP pattern than in the UIP pattern (Table 3, 4).Identiﬁcation of gelsolin
Gelsolin is cleaved into a C-terminal half (C-gelsolin) and N-
terminal half (N-gelsolin) by caspases or MMPs. Gelsolin was
detected in this study and was similarly cleaved into smaller pieces.
Peptides from tryptic digest identiﬁed by LC-MS/MS analysis are
shown in Fig. 2A. The identiﬁed peptides were located in the C-
terminal side, which meant that this gelsolin was C-gelsolin. We
also performed a western blot analysis to conﬁrm whether the
gelsolin was C-gelsolin or N-gelsolin. The gelsolin reacted with
anti-gelsolin polyclonal IgG, an antibody that recognizes the C-
terminal side of the protein (Fig. 2B, C).Measurement of gelsolin
We performed a western blot analysis for each BALF sample and
serum. The levels of C-gelsolin and N-gelsolin in BALF were
signiﬁcantly higher in the UIP pattern than in the OP pattern. No
signiﬁcant difference in full-length gelsolin (F-gelsolin) was found
between the two groups (Fig. 3A, B). No C-gelsolin or N-gelsolinwas
found in the serum samples, and the level of F-gelsolin found in
serum was not signiﬁcantly different between the two groups
(Fig. 4A, B).ELISA quantiﬁcations of gelsolin concentrations in serum and
BALF samples showed no signiﬁcant differences between the two
groups (Supplementary Fig. 1A, B). No correlation between the
serum gelsolin and BALF gelsolin was observed (Supplementary
Fig. 1C).
Tissue expression of gelsolin in the lungs
In UIP sample, C-gelsolin was positively stained within areas of
alveolar epithelium and ﬁbroblasts in the interstitium, N-gelsolin,
meanwhile, was positively stainedwithin areas of ciliated epithelial
metaplasia (Supplementary Fig. 2). In OP samples and normal
control samples, C-gelsolin and N-gelsolin were not stained within
areas of alveolar epithelium or interstitium (Supplementary Fig. 3).
In normal control samples, C-gelsolin was positively stained within
vascular endothelium.
Discussion
This study is the ﬁrst to report different patterns of BALF protein
expression analyzed by the proteomic approach in patients with
RA-ILD. The expression levels of six proteins signiﬁcantly differed
between the UIP pattern and OP pattern. Furthermore, fragmented
gelsolins were found to be signiﬁcantly increased in the UIP
pattern. Fragmented gelsolins may be associated with the patho-
genesis of ﬁbrosis in RA-ILD.
The normalization volumes of six proteins signiﬁcantly differed
between the UIP pattern and OP pattern, including gelsolin. Gel-
solin is a Ca2þ-regulated protein that severs, caps, and nucleates
actin ﬁlaments and serves the body as a ubiquitous, multifunctional
regulator of cell structure and metabolism.5 Yet C-gelsolin and N-
gelsolin, the two protein fragments of gelsolin, serve totally
different functions in pathology.18e20 F-gelsolin and fragmented
gelsolins can either enhance or inhibit apoptosis, depending on the
pathological condition and cell types and speciﬁc tissues
Table 2
BALF proteins identiﬁed in UIP and OP patterns.
Protein no. Protein AC Identiﬁcation
method
1 a-2 Macroglobulin P-01023 GM
2 Ceruloplasmin P-00450 GM, MS
3 Immunoglobulin A-S chain P-99003 GM, MS
4 Complement factor B P-00751 GM
5 a-1 B-glycoprotein P-04217 GM, MS
6 Hemopexin P-02790 GM, MS
7 Albumin P-02768 GM, MS
8 Transferrin P-02787 GM, MS
9 Complement C3b P-01024 GM
10 Immunoglobulin
heavy chain a
P-99002 GM, MS
11 a-2 antiplasmin P-08697 GM, MS
12 a-1 antichymotrypsin P-01011 GM, MS
13 a-2-HS-glycoprotein P-02765 GM, MS
14 Antithrombin III P-01008 GM, MS
15 Vitamin D-binding protein P-02774 GM, MS
16 a-1 antitrypsin P-01009 GM, MS
17 Zinc ﬁnger protein GLIS1 P-08151 MS
18 Apolipoprotein A-IV P-06727 GM
19 Gelsolin P-06396 MS
20 b-actin P-60709 GM, MS
21 Fibrinogen g, a chain P-02679 GM
22 Immunoglobulin
heavy chain m
P-99009 GM, MS
23 Immunoglobulin
heavy chain g
P-99006 GM
24 Zinc a-2-glycoprotein P-25311 GM
25 Haptoglobin b P-00737 GM, MS
26 Toll-like receptor 1 P-38593 MS
27 Pulmonary surfactant
protein A
P-07714 GM, MS
28 Immunoglobulin J chain P-01591 GM, MS
29 Complement factor I P-05156 GM
30 Immunoglobulin kappa
chain C region
P-01834 MS
31 C-reactive protein P-02741 GM, MS
32 Proapolipoprotein AI P-39133 GM
33 Immunoglobulin
light chain k, l
P-99007 GM
34 Apolipoprotein A-1 P-02647 GM
35 Glutathione S-transferase pi P-09211 GM, MS
36 Translationally controlled
tumor protein
P-13693 GM
37 Serum retinol binding protein P-02753 GM
38 Haptoglobin a P-00738 GM
Protein no.: refer to the annotations in Fig. 1.
AC, accession number from the SWISS-PROT database; GM, gel matching with the
two-dimensional gel electrophoresis database from SWISS-PROT; MS, LC-nESI-MS/
MS.
Table 4
Proteins with higher normalization volumes in the OP pattern than in the UIP
pattern.
Protein Theoretical
MW (kDa)/pI
Normalization
volume of
UIP (103)
Normalization
volume of
OP (103)
p
Value
a-1 antitrypsin 46.7/5.4 0 (0e26.5) 74.5
(31.3e94.3)
0.026
CRP 25.0/5.5 0 (0e0.023) 145.0
(106.0e161.5)
0.034
Haptoglobin 45.2/6.1 106.0 (42.5e291.5) 353.0
(312.5e771.8)
0.006
Surfactant
protein A
(isoform number 5)
26.2/5.1 95.0 (58.0e217.5) 480.0
(192.5e964.5)
0.019
Values are given as the numbers or medians (25th and 75th percentiles).
OP, organizing pneumonia; UIP, usual interstitial pneumonia.
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which disrupts the actin-DNase I interaction and releases DNase I
from actin to enhance apoptotic activity.25 In contrast, anti-
apoptotic functions have been exhibited by both C-gelsolin and F-
gelsolin.5,23 Resistance to apoptosis in ﬁbroblasts or epithelial cell
apoptosis is known to be involved in pulmonary ﬁbrosis.26 WeTable 3
Proteins with higher normalization volumes in the UIP pattern than in the OP
pattern.
Protein Theoretical
MW (kDa)/pI
Normalization volume
of UIP (103)
Normalization
volume of
OP (103)
p Value
Ig kappa chain
C region
11.6/5.6 540.0 (376.5e800.5) 187.5 (96.3e268.3) 0.011
Gelsolin 41.3/5.0 64.0 (57.5e94.5) 27.0 (13.0e39.5) 0.034
Values are given as the numbers or medians (25th and 75th percentiles).
UIP, usual interstitial pneumonia; OP, organizing pneumonia, Ig, Immunoglobulin.investigated the relationship between the fragmented gelsolins and
RA-ILD.
Fragmented gelsolins, which was detected in our study, were
thought to be cleaved by caspase-3. Caspase-3 cleaves gelsolin
between residues Asp352 and Gly353.5 However, MMP-3 cleaves
gelsolin at the different sites; between residues Asn416 and Val417
or Ala435 and Gln436.12 Coverage of the human gelsolin sequence
identiﬁed bymass spectrometry includes the peptide “SSHIANVER”
(Ser411Ser412His413Ile414Ala415Asn416Val417Glu418Arg419)Fig 2. Identiﬁcation of gelsolin by mass spectrometry and western blot analysis. (A)
Coverage of the human gelsolin sequence by tryptic peptides (in bold and underlined)
recovered from two two-dimensionally separated spots and identiﬁed by mass spec-
trometry. Note that the tryptic peptides cover only the carboxy terminal half. (B)
Western blot of BALF from UIP pooled samples immunostained with anti C-terminal
gelsolin antibody. The circled spot was nonspeciﬁc. (C) Magniﬁcation of the reacted
spot.
Fig 3. Western blot analysis of each BALF sample. (A) The C-terminal half of gelsolin
(C-gelsolin) was signiﬁcantly increased in the UIP pattern compared to the OP pattern.
There was no signiﬁcant difference in full-length gelsolin (F-gelsolin) between the two
groups. (B) The N-terminal half of gelsolin (N-gelsolin) was signiﬁcantly increased in
the UIP pattern compared to the OP pattern.
Fig 4. Western blot analysis of each serum sample. (A) The C-terminal half of gelsolin
(C-gelsolin) was not observed in the serum samples. There was no signiﬁcant differ-
ence in full-length gelsolin (F-gelsolin) between the two groups. (B) The N-terminal
half of gelsolin (N-gelsolin) was not observed in the serum samples.
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cleaved by MMP-3.
C-gelsolin and N-gelsolin levels in BALF were higher in the
UIP pattern than in the OP pattern in the present study. Oikonomou
et al. showed that caspase-3-mediated gelsolin fragments, C-gel-
solin and N-gelsolin, were increased in lung extracts from both
bleomycin- and LPS-challenged models. An absence of N-gelsolin, a
condition that leads to apoptotic cell detachment and nuclear
fragmentation by inducing cytoskeletal collapse, is important for
the protection of alveolar epithelial cells from bleomycin injury in
GSN/ mice. The role of C-gelsolin in this model was unknown.
Although gelsolin levels were increased in BALF samples from the
bleomycin-challenged model reported by Oikonomou et al. there
was no speciﬁc description of changes in C-gelsolin or N-gelsolin in
BALF.9,22 Our study also identiﬁed increases C-gelsolin and N-gel-
solin. The precursor of caspase-3 is localized in the cytoplasm,27
which tells us that the C-gelsolin and N-gelsolin fragments in
BALF were secreted from cells in the lung. C-gelsolin and F-gelsolin
are secreted by human bronchial epithelial cells into airway surface
liquid. In the study by Candiano et al. F-gelsolin and C-gelsolinwere
increased in the liquid of epithelia treated with IL-4 and BALF from
patients with bronchial asthma.18 While C-gelsolin and N-gelsolin
have opposite actions, both may contribute to the pulmonary
ﬁbrosis in RA-ILD if each acts on different cells. When we immu-
nohistochemically analyzed biopsied lung tissue to investigate
where the fragmented gelsolins were expressed in the lung, weonly found positive staining of C-gelsolinwithin areas of ﬁbroblasts
in the interstitium. The anti-apoptotic effect of C-gelsolin on ﬁ-
broblasts may contribute to the pathogenesis of ﬁbrosis in RA-ILD.
On the other hand, N-gelsolin might have a protective effect to the
development of pulmonary ﬁbrosis in RA-ILD. We evaluate the
association between the levels of fragmented gelsolins and clinical
ﬁndings, such as KL-6, SP-D, the results of pulmonary function test,
and ﬁbrotic scores on HRCT (data not shown). The levels of N-gel-
solinwere correlated with %VC, and were inversely-correlated with
KL-6 and SP-D. The levels of C-gelsolinwere not correlatedwith any
clinical ﬁndings. Since the role of N-gelsolin is unknown in our
study, further study is needed.
Samples from patients with the UIP and OP patterns did not
show C-gelsolin or N-gelsolin in serum in the present study. This
result indicates that fragmented gelsolins were expressed locally in
the lung and not derived from plasma. MMP-3 incubated with
human gelsolin generate gelsolin cleavage products in plasma
in vitro, yet no such cleavage products are observed in serum or
synovial ﬂuid of RA.12 MMPs, the enzymes thought to be mainly
responsible for extracellular matrix degradation, cleave plasma
gelsolin in vitro28,29 and rise to higher levels during inﬂammation.
It may be that the MMPs cleave gelsolin in vivo during RA, thereby
reducing the levels of cleavage products detected. Fragmented
gelsolins might be further degraded or rapidly cleared from the
K. Suhara et al. / Allergology International 65 (2016) 88e9594circulation.12 The levels of F-gelsolin in BALF and serum did not
signiﬁcantly differ between the UIP and OP patterns in the present
study. The major protein components in BALF are derived from
plasma.17 Given that plasma gelsolin is the principal circulating
protein,7 F-gelsolin in BALF might reﬂect the plasma gelsolin. Some
reports demonstrated decreases of plasma gelsolin in RA compared
to healthy controls or osteoarthritis patients.12,30 Other studies,
meanwhile, are contradictory. In some, gelsolin in synovial ﬂuid
was decreased in RA compared to osteoarthritis.11,12,31 In one more
recent study, gelsolin in synovial ﬂuid was ﬁve-fold higher in RA
than in healthy controls.32 Taken together, these reports support
the notion that plasma gelsolin is recruited to sites of inﬂammation.
Plasma gelsolin from blood might be trapped in the exposed actin
networks, leading to decreases in circulating plasma gelsolin.
Overall, however, the levels of plasma gelsolin are unrelated to the
disease activity of RA.12,30 Although we detected F-gelsolin and
N-gelsolin in our western blot analysis, we did not observe them in
our two-dimensional gels. We can propose two possible explana-
tions for this. First, the IPG strips may not have taken up the
F-gelsolin and N-gelsolin. Second, the F-gelsolin and N-gelsolin
may have been solved in the Laemmli sample buffer used for the
western blot analysis but not in the lysis buffer used for the 2-DE
analysis.
In previous studies our group has investigated the proteins
related to ﬁbrogenesis of the lungs in systemic sclerosis and chronic
hypersensitivity pneumonitis in proteomic analyses of BALF.15,33
We found no fragmented gelsolins among the proﬁbrotic proteins
identiﬁed in those studies. Hence, the fragmented gelsolins may be
speciﬁc proteins related to pulmonary ﬁbrosis in RA-ILD. Hypo-
thetically, caspase-3 cleaves gelsolin into C-gelsolin and N-gelsolin
in the ﬁbrotic lungs of patients with RA-ILD. C-gelsolin and
N-gelsolin are secreted into airway surface liquid. C-gelsolin, a
fragment with anti-apoptotic functions, is expressed in the ﬁbro-
blasts. Resistance to apoptosis in ﬁbroblasts leads to pulmonary
ﬁbrosis in RA-ILD. Gelsolin expression, on the other hand, is
increased in the ﬁbrotic lungs of patients with IPF. Oikonomou et al.
observed strong positive staining of gelsolin within areas of the
epithelium (bronchial and alveolar) and somewhat weaker staining
in adjacent ﬁbroblastic foci within the IPF lung.9 They made no
mention of fragmented gelsolins in their study, so the type of gel-
solin (full or fragmented) increased in the IPF lung was unspeciﬁed.
Further studies are needed to demonstrate the difference in gel-
solin expression between RA-ILD and IPF.
There were several limitations in this study. First, it was unclear
whether the alternations in protein expression were systemic or
local events in the lung. Second, we were unable to investigate
hydrophobic proteins by the 2-DE technique. Third, the relatively
small number of patients in this study limited our power to detect
statistical differences between the UIP and OP patterns. Fourth,
fragmented gelsolins may have been reﬂected in the ELISA results
along with the F-gelsolin. We were unable to determine whether
the ELISA kit recognizes the fragmented gelsolins.
In conclusions, we identiﬁed several proteins that may play
roles in the development of the differences between the UIP and OP
patterns in RA-ILD. Fragmented gelsolins may contribute to the
development of pulmonary ﬁbrosis in RA-ILD. Further studies to
clarify the role of gelsolin in the development of pulmonary ﬁbrosis
in RA-ILD are warranted.
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